Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amivantamab Combined With Intrathecal Pemetrexed for Leptomeningeal Metastasis From EGFR-Mutated Lung Adenocarcinoma
NCT07744529Phase 2Recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- May 2026
- Primary completion
- May 2028
- Countries
- 1
01
Overview
A Phase 2 trial of amivantamab in leptomeningeal metastasis (LM), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Started May 2026; status: recruiting.
02
Drugs
amivantamab
03
Conditions
leptomeningeal metastasis (LM)
Beyond the preview
Go deeper on NCT07744529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07744529.